PATENT CLAIM ANALYSIS

Application Number: 15904143
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "232200"]

Abstract:
The present invention provides compounds of any one of Formulae (I) to (V) (e.g., compounds of any one of Formulae (I-1) to (I-9)), and methods for treating Waldenström's macroglobulinemia (WM) and other B cell neoplams in a subject using the compounds. The methods comprise administering to a subject in need thereof an effective amount of the compounds. Also provided are methods to treat B cell neoplasms using the compounds in combination with inhibitors of Bruton's tyrosine kinase (BTK), interleukin-1 receptor-associated kinase 1 (IRAK1), interleukin-1 receptor-associated kinase 4 (IRAK4), bone marrow on X chromosome kinase (BMX), phosphoinositide 3-kinase (PI3K), transforming growth factor b-activated kinase-1 (TAK1), and/or a Src family kinase.

Claim (Index 25):
The compound of any of  claims 1 - 21 , wherein one R B  group is substituted or unsubstituted \u2014CH 2 -(piperazinyl).

Metadata:
- Claim Count in Document: 47.0
- Percentile: 88.0
- Lexical Diversity: 1.8481
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15847430', '15104132', '15104005', '14436387', '15114895']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8519006740013291
- 35 USC 102 Novelty (BERT): 0.6094484372834568
- Combined Prediction Score: 0.8276554503295418
- Mean Citation Score: 562.0104859999999
- Max Citation Score: 630.98505
- Similarity Product: 469.0580247245729

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test